Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva looks to amp up research collaborations, CEO says
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva CEO Schultz likely won't renew employment contract: reports
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Allergan on $40.5 Billion Drug Deal - The New York Times
Teva's flagship drug Austedo scores new approval at the FDA
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy - RealMoney
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva Stock Is Rising on Reports of an Opioid Settlement | Barron's
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Allergan to own 10% stake in Teva
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
